PMCB vs TSN · $8.6M cap vs P/E 22, rev $54.44B
PharmaCyte Biotech Inc (PMCB) versus Tyson Foods Inc (TSN) — a side-by-side from cached financials, not a winner call.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Tyson Foods Inc (TSN) is a farm products company listed on US.
Latest reported PMCB revenue for 2026-04-30 was $0. Net income was -$19.4M. PMCB currently screens at market cap $8.6M.
Latest reported TSN revenue for 2025-09-27 was $54.44B. Net income was $507.0M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
PMCB currently screens at market cap $8.6M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
Not investment advice. Open the PMCB and TSN stock pages for the full models.
Not investment advice.